BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21585522)

  • 21. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.
    Mühlbauer E; Gross E; Labucay K; Wolgast S; Peschke E
    Eur J Pharmacol; 2009 Mar; 606(1-3):61-71. PubMed ID: 19374844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets.
    Picinato MC; Hirata AE; Cipolla-Neto J; Curi R; Carvalho CR; Anhê GF; Carpinelli AR
    J Pineal Res; 2008 Jan; 44(1):88-94. PubMed ID: 18078453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
    Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
    Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells.
    Bach AG; Wolgast S; Mühlbauer E; Peschke E
    J Pineal Res; 2005 Oct; 39(3):316-23. PubMed ID: 16150114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic β-cells and human pancreatic islets.
    Kuehnen P; Laubner K; Raile K; Schöfl C; Jakob F; Pilz I; Päth G; Seufert J
    Endocrinology; 2011 May; 152(5):1800-8. PubMed ID: 21427225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
    Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
    Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion.
    Doi A; Shono T; Nishi M; Furuta H; Sasaki H; Nanjo K
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):885-90. PubMed ID: 16418280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin.
    Gerdin MJ; Masana MI; Rivera-Bermúdez MA; Hudson RL; Earnest DJ; Gillette MU; Dubocovich ML
    FASEB J; 2004 Nov; 18(14):1646-56. PubMed ID: 15522910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin-mediated insulin synthesis during endoplasmic reticulum stress involves HuD expression in rat insulinoma INS-1E cells.
    Yoo YM
    J Pineal Res; 2013 Sep; 55(2):207-20. PubMed ID: 23711134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
    Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
    Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon.
    Peschke E; Bähr I; Mühlbauer E
    Int J Mol Sci; 2013 Mar; 14(4):6981-7015. PubMed ID: 23535335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin and type 2 diabetes - a possible link?
    Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E
    J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
    Laychock SG; Modica ME; Cavanaugh CT
    Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
    Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
    J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin exerts an inhibitory effect on insulin gene transcription via MTNR1B and the downstream Raf‑1/ERK signaling pathway.
    Li Y; Wu H; Liu N; Cao X; Yang Z; Lu B; Hu R; Wang X; Wen J
    Int J Mol Med; 2018 Feb; 41(2):955-961. PubMed ID: 29207116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomolar melatonin influences insulin synthesis and secretion in rat insulinoma INS-1E cells.
    Jung EM; Joo SS; Yoo YM
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33571963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.
    Lyssenko V; Nagorny CL; Erdos MR; Wierup N; Jonsson A; Spégel P; Bugliani M; Saxena R; Fex M; Pulizzi N; Isomaa B; Tuomi T; Nilsson P; Kuusisto J; Tuomilehto J; Boehnke M; Altshuler D; Sundler F; Eriksson JG; Jackson AU; Laakso M; Marchetti P; Watanabe RM; Mulder H; Groop L
    Nat Genet; 2009 Jan; 41(1):82-8. PubMed ID: 19060908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin receptors in diabetes: a potential new therapeutical target?
    She M; Laudon M; Yin W
    Eur J Pharmacol; 2014 Dec; 744():220-3. PubMed ID: 25160745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.